|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001175,
umls-concept:C0008059,
umls-concept:C0021311,
umls-concept:C0026914,
umls-concept:C0055856,
umls-concept:C0087111,
umls-concept:C0205373,
umls-concept:C0205531,
umls-concept:C0226896,
umls-concept:C0442027,
umls-concept:C1521801,
umls-concept:C1527415
|
|
pubmed:issue |
5 Pt 1
|
|
pubmed:dateCreated |
1994-6-3
|
|
pubmed:abstractText |
To determine the safety, tolerance, pharmacokinetics, and antimycobacterial activity of orally administered clarithromycin in children with acquired immunodeficiency syndrome and disseminated Mycobacterium avium complex (MAC) infection.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0022-3476
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
124
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
807-14
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:8176574-AIDS-Related Opportunistic Infections,
pubmed-meshheading:8176574-Administration, Oral,
pubmed-meshheading:8176574-Adolescent,
pubmed-meshheading:8176574-Child,
pubmed-meshheading:8176574-Child, Preschool,
pubmed-meshheading:8176574-Clarithromycin,
pubmed-meshheading:8176574-Female,
pubmed-meshheading:8176574-Humans,
pubmed-meshheading:8176574-Infant,
pubmed-meshheading:8176574-Male,
pubmed-meshheading:8176574-Microbial Sensitivity Tests,
pubmed-meshheading:8176574-Mycobacterium avium Complex,
pubmed-meshheading:8176574-Mycobacterium avium-intracellulare Infection,
pubmed-meshheading:8176574-Recurrence
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
Orally administered clarithromycin for the treatment of systemic Mycobacterium avium complex infection in children with acquired immunodeficiency syndrome.
|
|
pubmed:affiliation |
Pediatric Branch, National Cancer Institute, Bethesda, Maryland.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial,
Clinical Trial, Phase I
|
